Ledger.Open graph →
SEC Form D · filed March 17, 2026

KALA BIO, Inc

Offering
$1.8M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ARLINGTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Yonatan Colman · Arlington, MADirectorBrendan Purdy · Quebec, Quebec, CanadaDirectorChaim Berger · Arlington, MADirectorAvi Minkowitz · Arlington, MAExec · DirectorHillel Posen · Arlington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗